Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells

Jurkat细胞 转染 嵌合抗原受体 电穿孔 细胞生物学 基因传递 分子生物学 细胞培养 生物 T细胞 化学 免疫学 免疫系统 生物化学 遗传学 基因
作者
Pedro Henrique Dias Moura Prazeres,Heloísa Athaydes Seabra Ferreira,Pedro Augusto Carvalho Costa,Walison da Silva,Marco Túllio Rodrigues Alves,Marshall Scott Padilla,Ajay S. Thatte,Anderson Kenedy Santos,Anderson Oliveira Lobo,Adriano de Paula Sabino,Helen Lima Del Puerto,Michael J. Mitchell,Pedro Pires Goulart Guimarães
出处
期刊:International Journal of Nanomedicine [Dove Medical Press]
卷期号:Volume 18: 5891-5904 被引量:49
标识
DOI:10.2147/ijn.s424723
摘要

Introduction: Chimeric antigen receptor (CAR) cell therapy represents a hallmark in cancer immunotherapy, with significant clinical results in the treatment of hematological tumors. However, current approved methods to engineer T cells to express CAR use viral vectors, which are integrative and have been associated with severe adverse effects due to constitutive expression of CAR. In this context, non-viral vectors such as ionizable lipid nanoparticles (LNPs) arise as an alternative to engineer CAR T cells with transient expression of CAR. Methods: Here, we formulated a mini-library of LNPs to deliver pDNA to T cells by varying the molar ratios of excipient lipids in each formulation. LNPs were characterized and screened in vitro using a T cell line (Jurkat). The optimized formulation was used ex vivo to engineer T cells derived from human peripheral blood mononuclear cells (PBMCs) for the expression of an anti-CD19 CAR (CAR-CD19BBz). The effectiveness of these CAR T cells was assessed in vitro against Raji (CD19 + ) cells. Results: LNPs formulated with different molar ratios of excipient lipids efficiently delivered pDNA to Jurkat cells with low cytotoxicity compared to conventional transfection methods, such as electroporation and lipofectamine. We show that CAR-CD19BBz expression in T cells was transient after transfection with LNPs. Jurkat cells transfected with our top-performing LNPs underwent activation when exposed to CD19 + target cells. Using our top-performing LNP-9-CAR, we were able to engineer human primary T cells to express CAR-CD19BBz, which elicited significant specific killing of CD19 + target cells in vitro. Conclusion: Collectively, our results show that LNP-mediated delivery of pDNA is a suitable method to engineer human T cells to express CAR, which holds promise for improving the production methods and broader application of this therapy in the future. Keywords: lipid nanoparticles, pDNA delivery, CAR T cells, cell engineering, cancer immunotherapy

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Jasper的应助被颖中竹子采纳,获得10
刚刚
刚刚
细心采蓝发布了新的文献求助10
1秒前
desert发布了新的文献求助30
1秒前
leyi完成签到,获得积分10
1秒前
Gxt完成签到,获得积分10
1秒前
Daisy完成签到,获得积分10
1秒前
wu完成签到,获得积分10
1秒前
cheng完成签到,获得积分10
2秒前
tang发布了新的文献求助10
2秒前
小马甲的应助被NeonEchoes采纳,获得30
2秒前
2秒前
小小怪完成签到,获得积分10
2秒前
甜甜圈完成签到,获得积分10
3秒前
eeee发布了新的文献求助10
3秒前
朴实舞蹈发布了新的文献求助10
3秒前
lcdt完成签到,获得积分10
3秒前
3秒前
昆望完成签到,获得积分10
3秒前
Sunny完成签到 ,获得积分10
3秒前
4秒前
4秒前
lucaaa完成签到,获得积分10
4秒前
4秒前
123发布了新的文献求助50
4秒前
乐乐的应助被zhang采纳,获得30
4秒前
5秒前
研友_VZG7GZ的应助被jeff采纳,获得10
5秒前
阿biuu完成签到,获得积分10
5秒前
5秒前
残月下的樱花完成签到,获得积分10
5秒前
5秒前
大力发布了新的文献求助10
6秒前
0per完成签到,获得积分10
6秒前
CodeCraft的应助被风吹麦浪采纳,获得10
6秒前
今天签到了吗完成签到,获得积分10
6秒前
Owen的应助被mingxu采纳,获得10
7秒前
含糊的幻丝完成签到 ,获得积分10
7秒前
充电宝的应助被in2dabyss采纳,获得10
7秒前
小祁完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180617
求助须知:如何正确求助?哪些是违规求助? 9570702
关于积分的说明 21813868
捐赠科研通 7776860
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557571
邀请新用户注册赠送积分活动 2479253